ALPS ADVISORS INC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 165 filers reported holding ACORDA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$275,000
-64.4%
95,845
-4.9%
0.00%
-66.7%
Q2 2019$773,000
-49.4%
100,745
-12.4%
0.01%
-45.5%
Q1 2019$1,529,000
-10.7%
115,052
+4.7%
0.01%
-15.4%
Q4 2018$1,712,000
+3.7%
109,907
+30.8%
0.01%
+18.2%
Q3 2018$1,651,000
-15.8%
84,028
+23.0%
0.01%
-15.4%
Q2 2018$1,960,000
+31.6%
68,306
+8.5%
0.01%
+8.3%
Q1 2018$1,489,000
+34.0%
62,973
+21.6%
0.01%
+50.0%
Q4 2017$1,111,000
+2.2%
51,801
+12.7%
0.01%0.0%
Q3 2017$1,087,000
+31.0%
45,944
+9.1%
0.01%
+33.3%
Q2 2017$830,000
-1.0%
42,115
+5.5%
0.01%0.0%
Q1 2017$838,000
+0.6%
39,925
-9.9%
0.01%0.0%
Q4 2016$833,000
-32.2%
44,313
-24.7%
0.01%
-40.0%
Q3 2016$1,228,000
-25.6%
58,819
-9.1%
0.01%
-33.3%
Q2 2016$1,651,000
+21.3%
64,714
+25.8%
0.02%
+7.1%
Q1 2016$1,361,000
-44.0%
51,450
-9.5%
0.01%
-41.7%
Q4 2015$2,432,000
-86.3%
56,850
-15.2%
0.02%
+26.3%
Q3 2015$17,779,000
+1155.6%
67,065
+57.8%
0.02%
+58.3%
Q2 2015$1,416,000
+101.7%
42,496
+101.4%
0.01%
+100.0%
Q1 2015$702,00021,0970.01%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
PFM Health Sciences, LP 1,526,174$1,423,0000.12%
GSA CAPITAL PARTNERS LLP 250,271$233,0000.06%
Spark Investment Management LLC 110,300$102,0000.05%
SALZHAUER MICHAEL 30,000$28,0000.05%
HAP Trading, LLC 260,800$532,0000.04%
Point72 Asset Management, L.P. 1,589,600$1,482,0000.01%
DLD Asset Management, LP 208,400$196,0000.01%
ACADIAN ASSET MANAGEMENT LLC 1,893,678$1,765,0000.01%
EVERENCE CAPITAL MANAGEMENT INC 65,680$61,0000.01%
Benin Management CORP 11,714$11,0000.01%
View complete list of ACORDA THERAPEUTICS INC shareholders